IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Verve Therapeutics Inc

CUSIP: 92539P101 | 410 institutional holders

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

DekaBank Deutsche Girozentrale24,000
0.0% of portfolio›$344
StyleTurnoverLocationFiled
DekaBank Deutsche Girozentrale
24,000$3440.0%CoreLowFrankfurt, Hong Kong2026-01-28